Patient-reported outcomes and health-related quality of life in effectiveness studies: pros and cons-Reference-Cited by-同舟云学术

Patient-reported outcomes and health-related quality of life in effectiveness studies: pros and cons

Published:2006 Issue:3 Volume:67 Page:193-201
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Marquis Patrick,Arnould Benoit,Acquadro Catherine,Roberts W. Mark

Publisher

Wiley

Subject

Drug Discovery

Reference71 articles.

1. Academy of Managed Care Pharmacy. The AMCP format for formulary submissions. Version 2.1. On Foundation for Managed Care Pharmacy website (updated 2005 Apr; cited 5 A.D. May 2). Available from: http://www.fmcpnet.org/.

2. Incorporating the Patient's Perspective into Drug Development and Communication: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSSD and Biologic Therapy: Real-Life Data in 417 Patients with Moderate to Severe Psoriasis;Reviews on Recent Clinical Trials;2022-08

2. The association between patient-reported outcomes (PROs) and patient participation in chronic care: A scoping review;Patient Education and Counseling;2022-07

3. “Il faut continuer à poser des questions” patient reported outcome measures in cystic fibrosis: An anthropological perspective;Journal of Cystic Fibrosis;2021-11

4. Development and validation of a set of patient reported outcome measures to assess effectiveness of asthma prophylaxis;BMC Pulmonary Medicine;2021-09-17

5. The Purpose of Patient-Reported Outcome (PRO) Post Its Digitalization and Integration into Clinical Practice: An Interdisciplinary Redefinition Resembling PROs Theoretical and Practical Evolvement;Applied Sciences;2020-10-26